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MetoprololinAdditionto ACE-inhibitoreCaueea
Regreeaionof LeftVentricuierDiiatetionand
increaaeeExerciseEiectionFractionin iachemic
Cardiomyopathy -
F.Waagstein, for the Metoprolol in Mild to Moderate Heart Failure study
group. Coordinating Center: Wa//anbergLaboratory Sah/grenska University
Hospital, GL$teborg,Sweden
The possibility of revereal of poet myWardial infarction dilatation after long-
term beta-blockade has been questioned both by clinicians and experimental
researchers. For this reason the present study was undertaken.
Patients and Metfrods:93 patients, mean age 53.3 yeare, with stable mild
to moderate congestive heart failure in NYHAclass II (52Yo)and Ill (46%)with
ejection fraction (EF)s 0.40 (mean 0.29) were given metoprolol (M) 50 mg
t.i.d. for 6 montha or placeba (P) in addition to ACEI (91%), diuretics (71%)
and digoxin (51Yo). 64% had a documented acute myceardial infarction
Z6 months earlier. EF, left ventricular enddiastolic volume (LVEDV) and
left ventricular endsyatolic volume (LVESV) were measured with equilibrium
redionuclide angiography (ERNA) at rest and during submaximal exercise
(SME).
Results: Effects of metoprolol after 6 months compared with placelxI
(analysis of covtvimcewithbaseline value aa COvariate).
RestingEF +0.080 p=o.ool 0.036-0.124
SME-EF +0.077 p.o.oo4 0.026-0.127
LVEDVrest(ml) –22.4 p=o.029 2.442.3
LVESVrest (ml) –25.3 p.o.oos 7.8-43.0
SME-LVEPV(ml) –23.5 p=o.oel –1.248.2
SME-LVESV (ml) –31.5 p .0.005 9.8-53.1
Conclusion: Long-term pl-blockada in addition to treatment with ACEI
reverses post-AMl dilatation during SME and improves submaximal EF to a
similar degree as resting EF.
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753-1 RevascuiarizstionimprovesSurvivain Patients
WithSevereLeftVentricularDysfunctionand
ContractileReserveByDobutemineStresa
Echocardiography
G.M. Vatii, S.P. Reddy, J.T. Tauke, M.A. Parker, R.O. Bonow,
F.A.Chaudhw. Nor?hwestamUnivereify SchOO/of fdedicine, Chicago, IL,
USA
Low dose dobutamine stress echocardiography (OSE) is an established
method for identification of contractile reeetve (CR) as a marker of myocar-
dial viability inptewith CAD and LVdysfunotionwith excellent pradictivevalue
for post revascularfzation wall motion improvement. Whether this translates
into improved survival has not bean documented. Eighty pte (mean age 65
+ 11,74% males) with LV dyafunotion (LV EFs 40%) and documented CAD
underwent DSE. Myooardial segments were scored at baseline and at IW
dose dobutemine (2.5-20 @kg/rein) using a 16 segment model. Significant
CR was defined as an improvement of baseline wall motion score in 25 seg-
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ments with low dose dobutamine. Significant CR was demonstrated in 56 pts
(73%). Among pts with CR, 24 (41%) underwent coronary revascularization
(15 CABG, 9 PTCA). Long-term follow-up was obtained in all pts (mean 30.0
+9.6 months). There was no significant difference in resting ejection fraction
between pts with CR treated with or without revascularization (27 + 7% vs
26& 7%, p = NS). There were 12 cardiac deaths. Actuarial cardiac mortality
was greater in patients treated medically compared to revaeoularization, es
shown in the figure.
These date support the concept that in pta with significant CR by DSE,
survival is favorably enhanced by revascularization independent of resting
ejection fraction.
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1753-21incrementaiVaifIeOfDObUtSmineStress
Echocardiographyin PredictingCardiacEvents
AmongPatientsWithLeftVentricularDysfunction
S.-C. Chuah, R.B. McCUIIY,V.L. Roger, J.B. Seward, P.A. Peilikka. Mayo
Clinic, Rochestec MN, USA
Left ventricular dysfunction is recognized as a predictor of cardiac events.
Whether patients can be further stratified with dobutamine stress eohooar-
diography (DSE) is unknown. To determine the incremental value of DSE
in predicting cardiac events (myocardial infarction (Ml) and cardiac death)
among patienta with left ventricular dysfunction (ejection fraction -=50%),we
evaluated 173 consecutive patients (141 men, mean age 71 + 9 yre, mean
ejection fraction (EF) 35 * S%) who had DSE from January 1991 to De-
cember 1992. During a follow-up of up to 45 months, there were 32 cardiac
events: 6 nonfatal Ml and 24 cardiac deaths. Nine of 24 clinical, reat echo,
and stress echo variables tested were univariate predictors of time to first
cardiac event (p < 0.05). These were: previous Ml, history of congestive
heart failure (CHF), rest EF, rest wall motion smre index (WMSI), percent
abnormal segments with stress, number of fixed abnormal segments with
stress, and failure of left ventricular endsystolic volume to decrease with
stress (LVESVA).
By multivariate analysis, there were 3’independent predictors of outcome:
x2 p-value
Historyof CHF 9.6 0.002
Numberfixedabnormalsegments 5,5 0.027
AbnormalLVESVA 4.9 0.019
The stress echo data provided incremental prognostic information when
added to either clinicel or rest echo data.
Model X2 p-value
Clinical+ Rest Echo 19 <0.0001
Clinical+ Rest Echo+ Stress Echo 28 <0.0031
Conclusion.’Among patients with left ventricular dysfunction, DSE has
significant incremental value in predicting cardiac events compared to clinical
date and rest echocardiography.
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m7533 DifferentPrognosticSignificanceof MyocardiaiViabiiityandischemiaDetectedby Dobutemine
StressEchocardio9raPhYin Patientswitha Firat
AcuteMyocardiainfarction
L. Lenzarini, A. Poli, R. Fetiveau, C. Cavalotti, A. Repatto, P. Diotallevi,
M. Previtali. Dept. Cardio/ogx University of Pavia, /RCCS-S. Matted
Hospital, Pavia, Italy
The purpose of this study was to evaluate the prognostic significance of
myocardial viability (V) and iechemia (1) detected by Dobutamine etreas
echocerdiography (DSE) in pts with a first acute myooerdial infarction (AMI)
treated with thrombolysis. DSE (5-40 @kg/rein followed byatropine up to 1
mg when needed)was performed in 146 pts (140 men, mean age53 +6yre)
with a first AMI (81 anterior, 108 Q-wave AMI) at a mean of 7 * 3 days from
AMI. Myooardial V wee diagnosed when an improvement of >/=2 basally
asynergic segments in tha infarct area (1A)occurred at low doses; myooardial
I was diagnosed when a deterioration of contractility in aegmente improved
at low doses or a new asynergy in the 1Adeveloped at high doses. All pte
were followad up for a mean of 13 + 12 months to evaluate hard eventa
(death+AMl), spontaneous events (SE) (hard events+unsteble angina) and
total events (TE) (SE+revascularization procedures). DSE identified 3groupa
of pts: Group 1 (23 pts, 15%) with V and no 1;Group 2 (92 pte, 62%) with
both V and 1;Group 3 (33 pts, 33%) without V. The clinical end points had
the following distribution:
